In patients hospitalized for COVID-19, the presence of pulmonary hypertension may be associated with more severe presentation of the disease and worse in-hospital outcomes.
In patients with COVID-19–related ARDS, increased troponin T levels were found to be common and may be linked to disease severity.
Women who had previously taken β-blockers for hypertension were found to be at increased risk for heart failure in new-onset coronary heart disease.
Electrocardiographic sign of left ventricular hypertrophy was found to predict HF among women.
The Norton scoring system was found to be a powerful predictor of both short- and long-term outcomes in patients with acute heart failure.
The use of angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers is associated with lower risk of colorectal cancer risk that develops within three years after index colonoscopy.
Detection of left ventricular hypertrophy with electrocardiographic Sokolow-Lyon or Cornell voltage criteria was found to predict stroke and improve risk stratification among patients with hypertension.
Increased Achilles tendon thickness was found to be an independent predictor of carotid atherosclerosis in patients at high or very high cardiovascular risk.
The American Heart Association outlined several considerations for the management of pregnant women with CVD or CVD-related conditions.
Balloon pulmonary angioplasty and pulmonary vasodilators were both found to improve functional and hemodynamic outcomes in patients with inoperable chronic thromboembolic pulmonary hypertension.